| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 12 |
| 1 | METFORMIN | 8 |
| 2 | METFORMIN ER 500 MG | 4 |
| 3 | METFORMIN ER 750 MG | 4 |
| 4 | METFORMIN HYDROCHLORIDE | 4 |
| 5 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 4 |
| 6 | METFORMIN HYDROCHLORIDE TABLET | 4 |
| 7 | METFORMIN HYDROCHLORIDE TABLETS | 4 |
| 8 | EMPAGLIFLOZIN | 3 |
| 9 | FUROSEMIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MECASERMIN | 1 | 0.0012 |
| 1 | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 2 | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 3 | INSULIN GLULISINE | 2 | 0.0002 |
| 4 | TELOTRISTAT ETHYL | 1 | 0.0002 |
| 5 | VINORELBINE | 1 | 0.0001 |
| 6 | HUMAN INSULIN | 1 | 0.0001 |
| 7 | INSULIN GLARGINE-YFGN | 3 | 0.0001 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 1 | 0.0001 |
| 9 | TRAVOPROST | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 18 |
| 1 | Insulin [EPC] | 3 |
| 2 | Loop Diuretic [EPC] | 3 |
| 3 | Proton Pump Inhibitor [EPC] | 3 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 3 |
| 5 | Aldosterone Antagonist [EPC] | 2 |
| 6 | Atypical Antipsychotic [EPC] | 2 |
| 7 | Thiazide-like Diuretic [EPC] | 2 |
| 8 | Aromatase Inhibitor [EPC] | 1 |
| 9 | BCL-2 Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Insulin [EPC] | 3 | 0.0001 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 4 | Thiazide-like Diuretic [EPC] | 2 | 0.0000 |
| 5 | Insulin Analog [EPC] | 18 | 0.0000 |
| 6 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |